Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Cefuroxime, beta-lactamase inhibitor containing composition

A technology of cefuroxime and lactamase, which is applied in the direction of antibacterial drugs, can solve the problems affecting clinical anti-infection treatment and the rising rate of resistance to β-lactam antibiotics

Inactive Publication Date: 2004-12-29
SUZHOU DAWNRAYS PHARM CO LTD
View PDF0 Cites 15 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] Cefuroxime is a second-generation cephalosporin with broad-spectrum antibacterial effect. In recent years, due to the widespread emergence of clinical β-lactamase-producing strains, especially the emergence of extended-spectrum β-lactamase, β-lactams The rate of antibiotic resistance continues to rise, which seriously affects the clinical anti-infective treatment

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Cefuroxime, beta-lactamase inhibitor containing composition
  • Cefuroxime, beta-lactamase inhibitor containing composition
  • Cefuroxime, beta-lactamase inhibitor containing composition

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029] Embodiment 1: cefuroxime sodium sulbactam sodium (0.75g / 0.75g) powder injection for injection

[0030] Take cefuroxime sodium (calculated as cefuroxime) and sodium sulbactam (calculated as sulbactam) respectively and mix them uniformly in a mixer according to the technical specifications of aseptic operation in a 1:1 weight ratio, and mix them in a local 100-level environment. The lower part is packed in the sterilized vial, and the stopper and cap are obtained to obtain cefuroxime sodium sulbactam sodium powder injection for injection.

Embodiment 2

[0031] Embodiment 2: cefuroxime sodium sulbactam sodium for injection (0.75g / 0.75g) freeze-dried preparation

[0032] Dissolve cefuroxime sodium (calculated as cefuroxime) and sodium sulbactam (calculated as sulbactam) in an appropriate amount of water for injection at a weight ratio of 1:1, filter and sterilize with a 0.22 μm microporous membrane , put it on a plate, and pre-freeze at 1°C / min until the temperature drops to -35°C for 2 hours, and then heat it up to -5°C at a rate of 5°C / hour under the condition of a condensing -32°C drying oven with a vacuum of 200 , maintained for 20 hours, and raised to 10°C, maintained for 10 hours. Then put on the plug and press the cap to obtain the freeze-dried preparation of cefuroxime sodium sulbactam sodium for injection.

Embodiment 3

[0033] Embodiment 3: cefuroxime sodium sulbactam sodium powder for injection (0.75g / 0.325g)

[0034] Cefuroxime sodium sulbactam sodium (2:1) powder injection was prepared according to the operation procedure and process of Example 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention is one kind of antiseptic medicine composition containing antibiotic cefuroxime and beta-lactamase inhibitor in the weight ratio of 0.5-20. The said medicine composition as new generation of antiseptic medicine composition has the advantages of wide antiseptic spectrum and strong antiseptic effect.

Description

technical field [0001] The invention relates to β-lactam antibiotics, in particular to a novel compound antibiotic composed of cefuroxime drugs and β-lactamase inhibitors. The composition has strong effects on sensitive bacteria and enzyme-producing bacteria, and has wider antibacterial spectrum and stronger antibacterial effect. Background technique [0002] Bacterial drug resistance is a natural selection for bacteria to submit to the selective pressure of antibiotics and continue. The main mechanism is that bacteria produce β-lactamase, which acts on β-lactam antibiotics to open the β-lactam ring and Inactivate. This kind of drug resistance can not only spread between bacteria, but also spread around the world. Infections caused by drug-resistant strains are often refractory or even fatal. Therefore, the research on the trend of bacterial drug resistance and New antibacterial means have become a long-term and even eternal topic for human beings to protect their own exis...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/546A61P31/04
Inventor 初虹
Owner SUZHOU DAWNRAYS PHARM CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com